The Form 4 filings hit hard yesterday: CoreWeave's GC and CEO unloaded $156M in stock across three days. Cerebras' CEO dumped another $241M. United Therapeutics' General Counsel liquidated $142M. This isn't option expiry tax-loss harvesting — these are C-suite execs selling into strength when their equity is worth the most. CoreWeave's Intrator sold $63M worth at $81+ after the stock ripped 400% in 6 months. That's not portfolio rebalancing, that's positioning.

Research these companies